Nemolizumab Sustains Atopic Dermatitis Control Through 3 Years
Long-term data show nemolizumab maintained skin clearance and itch control in atopic dermatitis patients through 3 years of continuous therapy, reinforcing its durability profile.
Topic
Long Term Efficacy
Topic
Long Term Efficacy
Icotrokinra Holds Skin Clearance at High-Impact Psoriasis Sites at 2 Years
Icotrokinra sustained skin clearance at high-impact psoriasis sites through 2 years, per Dermatology Times. The milestone extends…
Tildrakizumab Delivers Long-Term Control in Hard-to-Treat Psoriasis Areas
AJMC reports tildrakizumab sustained long-term psoriasis control in hard-to-treat areas such as scalp, palms and soles, strengthe…